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Areas in which malaria is not highly endemic are suitable 
for malaria elimination, but assessing transmission is difﬁ  -
cult because of lack of sensitivity of commonly used meth-
ods. We evaluated serologic markers for detecting variation 
in malaria exposure in Somalia. Plasmodium falciparum or 
P. vivax was not detected by microscopy in cross-sectional 
surveys of samples from persons during the dry (0/1,178) 
and wet (0/1,128) seasons. Antibody responses against P. 
falciparum or P. vivax were detected in 17.9% (179/1,001) 
and 19.3% (202/1,044) of persons tested. Reactivity against 
P. falciparum was signiﬁ  cantly different between 3 villages 
(p<0.001); clusters of seroreactivity were present. Distance 
to the nearest seasonal river was negatively associated with 
P. falciparum (p = 0.028) and P. vivax seroreactivity (p = 
0.016). Serologic markers are a promising tool for detecting 
spatial variation in malaria exposure and evaluating malaria 
control efforts in areas where transmission has decreased 
to levels below the detection limit of microscopy.
S
ub-Saharan Africa has the highest incidence of malaria 
caused by Plasmodium falciparum. Almost all areas 
where P. falciparum parasite prevalence is >50% in the 
general population are located in Africa (1). However, ma-
laria is not uniformly distributed (1,2) and many parts of 
Africa are characterized by low transmission intensity of 
malaria (1). These areas are considered suitable for inten-
sive malaria control and disease elimination (3,4).
Assessing malaria transmission intensity and evaluat-
ing interventions are complicated at low levels of malaria 
transmission. Assessing transmission intensity directly by 
determining the exposure to malaria-infected mosquitoes 
(entomologic inoculation rate [EIR]) is difﬁ  cult when mos-
quito numbers are low, sometimes below the detection lim-
its of commonly used trapping methods (5,6), and spatial 
and temporal variations in mosquito densities necessitate 
long-term intensive sampling (5,7,8). Determination of ma-
laria parasite prevalence in the human population is a com-
monly used alternative (9), but it also becomes less reliable 
as an indicator of transmission intensity when endemicity 
is low (3,9,10). Therefore, an alternative method is needed 
to assess transmission intensity, evaluate interventions, and 
obtain information for control programs in areas of low en-
demicity.
Prevalence of antibodies against malaria parasites has 
been explored as a means of assessing malaria transmis-
sion intensity (11–13). Antibody seroconversion rates are 
less susceptible to seasonal ﬂ  uctuations in malaria expo-
sure (11,12), show a tight correlation with EIR (12,13), and 
show potential to detect recent changes in malaria transmis-
sion intensity (14). Serologic markers could be particularly 
useful in areas of low endemicity, where it may be easier to 
detect relatively long-lasting antibody responses than a low 
prevalence of malaria infections in the human population or 
infected mosquitoes. We used serologic markers of expo-
sure to determine spatial variation in malaria transmission 
intensity in an area of low endemicity in Somalia (15).
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Methods
Study Area
This study was conducted in the Gebiley District in 
Somaliland in northwestern Somalia. The district has a pre-
dominantly arid landscape with a few seasonal rivers and 
patches of irrigated farmlands. It is an area of intense sea-
sonal rainfall with an average annual precipitation of 59.9 
mm (2004–2007) and 2 peaks in rainfall in April and Au-
gust. Three moderately sized communities were randomly 
selected from census maps by using spatial random sampling 
techniques in Arcview version 3.2 (Environmental Systems 
Research Institute, Redlands, CA, USA) (16). These com-
munities were the villages of Xuunshaley (9.72140°N, 
43.42416°E), Badahabo (9.68497°N, 43.65616°E), and 
Ceel-Bardaale (9.81777°N, 43.47455°E). The research 
protocol was reviewed and approved by the Research Eth-
ics Review Committee of the World Health Organization 
(RPC246-EMRO) and the Ethical Committee of the Minis-
try of Health and Labor, Republic of Somaliland.
Data Collection
Two cross-sectional surveys were conducted. The ﬁ  rst 
survey was conducted in March 2008 to determine parasite 
carriage at the end of the dry season (16). The purpose of 
the survey and the procedures were ﬁ  rst discussed with the 
clan elders; thereafter, each household was visited, and in-
formed consent was sought from each head of household. 
Households that agreed to participate were geolocated by 
using a global positioning system (Garmin eTrex; Garmin 
International, Inc., Olathe, KS, USA), and information was 
collected on demographic characteristics, bed net use, and 
travel history of the participants. Distance to seasonal rivers 
or other water bodies and distance to the nearest livestock 
enclosure was determined by using the global positioning 
system.
Individual written consent was obtained from all liter-
ate adults; illiterate adults provided consent by a thumbprint 
in the presence of an independent literate adult witness. 
For children <18 years of age, consent was obtained from 
parents or guardians, and children 12–18 years of age who 
could not write also provided consent by a thumb print.
One ﬁ  ngerprick blood sample was obtained from each 
respondent for the preparation of a P. falciparum antigen–
speciﬁ  c rapid diagnostic test (RDT) (Paracheck-Pf; Orchid 
Biomedical Systems, Goa, India) sample and thick and thin 
blood smears. One-hundred high-power microscopic ﬁ  elds 
were examined and an additional 100 ﬁ  elds were exam-
ined if the ﬁ  rst 100 ﬁ  elds were negative. RDT results were 
used for treatment with sulfadoxine-pyrimethamine and 3 
doses of artesunate according to national guidelines. A sec-
ond cross-sectional survey was conducted at the end of the 
wet season (August–September 2008) by using procedures 
identical to those described above, except that part of the 
ﬁ  ngerprick blood sample was placed on ﬁ  lter paper (3 MM; 
Whatman, Maidstone, UK) as described by Corran et al. 
(17).
Entomologic Surveys
Presence of Anopheles spp. mosquitoes in the area was 
determined by larvae collections in all permanent water 
bodies (artiﬁ  cial rain water reservoirs, wells, boreholes, 
stagnant storage pits, and riverbeds) in the 3 villages at the 
end of the wet season. Locally produced 250-mL dippers 
with a white surface were used. Five to 10 dips were made 
in the large water bodies and the presence of Anopheles 
spp. larvae was visually assessed and recorded.
Elution of Serum
Filter paper samples were stored at 4°C with desiccant 
until processed. A 3.5-mm blood spot, equivalent to ≈3 μL 
of blood (17), was punched from the ﬁ  lter paper and placed 
in a labeled well of a low-binding 96-well titer plate. A to-
tal of 300 μL of reconstitution buffer (phosphate-buffered 
saline [PBS], 0.05%Tween, and 0.1% [wt/vol] sodium az-
ide) was added, and plates were sealed and rocked gently 
at room temperature overnight and subsequently stored at 
4°C. The reconstituted blood spot solution was equivalent 
to a 1:100 dilution of whole blood or a 1:200 dilution of 
serum.
ELISAs
All reconstituted ﬁ  lter paper spots were tested at a 
ﬁ  nal serum dilution equivalent of 1:1,000 for human im-
munoglobulin G antibodies against P. falciparum mero-
zoite surface protein 119 (MSP-119) and 1:2,000 for anti-
bodies against apical membrane antigen 1 (AMA-1) by 
using described ELISA methods (12,17). Brieﬂ  y, recom-
binant MSP-119 (Wellcome genotype) and AMA-1 (3D7) 
were coated overnight at 4°C at a concentration of 0.5 μg/
mL. Plates were washed by using PBS, 0.05% Tween 20 
(PBS/T) and blocked for 3 h with 1% (wt/vol) skim milk 
powder in PBS/T. Positive controls (a pool of hyperim-
mune serum) and negative controls (European malaria-
negative volunteers) were added in duplicate to each plate. 
The plates were washed and horseradish peroxidase–conju-
gated rabbit anti-human immunoglobulin G (Dako, Rosk-
ilde, Denmark) (1:5,000 dilution in PBS/T) was added to 
all wells. Plates were developed for 20 min by using an 
o-phenylenediamine dihydrochloride substrate solution. 
Reactions were stopped with 2 mol/L H2SO4. Plates were 
read immediately at 492 nm and optical density (OD) val-
ues recorded. For P. vivax, an identical protocol was used 
with MSP-119 (0. 5 μg/mL) (18) and AMA-1 (0. 5 μg/mL). 
Serum in this protocol was used at 1:1,000 dilutions for 
both antigens.
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Data Management and Statistical Analyses
Data were double-entered and imported into STATA 
version 10 (StataCorp LP, College Station, TX, USA). Du-
plicate OD results were averaged and normalized against 
the positive control sample on each plate. A cutoff value 
above which samples were considered antibody positive 
was deﬁ  ned by using a mixture model as described (17). 
Distribution of normalized OD values was ﬁ  tted as the sum 
of 2 Gaussian distributions by using maximum-likelihood 
methods. The mean OD of the Gaussian distribution cor-
responding to the seronegative population plus 3 SD val-
ues was used as the cutoff value for seropositivity (J. Cook 
et al., unpub. data). A separate cutoff value was generated 
for each antigen (MSP-119 and AMA-1) for each species 
(P. vivax and P. falciparum). The seroconversion rate was 
estimated by ﬁ  tting a simple reversible catalytic model to 
the measured seroprevalence by age in years by using max-
imum-likelihood methods. The serologic-derived annual 
EIR was then estimated by using the MSP-119 seroconver-
sion rate and a calibration curve derived from determined 
values (11).The titer of antibody responses was estimated 
by using the formula dilution/[maximum OD/(OD test se-
rum – minimum OD) – 1]; the median titer and interquartile 
range (IQR) are given. Because of low overall antibody 
prevalence, antibody responses were combined by species 
to determine the presence of any reactivity against P. falci-
parum or P. vivax. As a quantitative measure of reactivity 
to either malaria species, the highest titer in the MSP-119 
and AMA-1 ELISAs was used.
Factors associated with P. falciparum or P. vivax se-
roreactivity were determined for each village separately by 
using generalized estimating equations adjusting for corre-
lation between observations from the same household. The 
following factors were tested in the models: age in years, 
distance to the nearest seasonal river (in 100 m), distance 
to the nearest enclosure of livestock (in 100 m), number of 
household members, number of houses in a 100-m radius, 
rooﬁ  ng material, wall material, ﬂ  oor material, travel histo-
ry, recent or regular bed net use, and an indicator of house-
hold wealth. The household wealth index was calculated on 
the basis of principal component analysis on characteristics 
such as ownership of a television, radio, telephone, bicycle, 
motorbike, cattle, and access to electricity (19). Variables 
that were signiﬁ  cant at p = 0.10 in univariate analyses were 
added to the multivariate model and retained in the ﬁ  nal 
multivariate model if their association with immune re-
sponses was statistically signiﬁ  cant at p<0.05.
For detection of spatial clusters in immune responses, 
age-adjusted log10-transformed ODs were calculated as de-
scribed by Wilson et al (20). First, Loess lines were ﬁ  tted to 
scatter plots of age against log-transformed ODs for each 
antigen separately. For P. falciparum MSP-119 and P. vivax 
AMA-1, the linear regression was split at 49 and 46 years of 
age. Log-transformed ODs were adjusted for age by linear 
regression. SaTScan software (21) was used for detection 
of spatial clustering in log-transformed age-adjusted OD 
values by using the normal probability model. A circular-
shaped window was used to systematically scan the area of 
each village separately; statistical signiﬁ  cance of the clus-
ters was explored by using 999 Monte Carlo replications to 
ensure adequate power for deﬁ  ning clusters. The upper limit 
was speciﬁ  ed as 50% of the village population. Signiﬁ  cant 
increases in ODs were detected by calculation of the likeli-
hood ratio for each window. Only clusters were reported 
that appeared for MSP-119, AMA-1, and their combined 
age-adjusted ODs. Maps were made by using ArcGIS ver-
sion 9.1 (Environmental Systems Research Institute).
Results
The 2 cross-sectional surveys were completed in 
March (dry season, n = 1,178) and August–September (wet 
season, n = 1,128) 2008. These surveys were characterized 
by a clear seasonality with no rainfall detected during No-
vember 2007–March 2008 and a median monthly rainfall 
of 114.5 mm in April–August 2008. None of the survey 
participants were positive by rapid diagnostic test, and P. 
falciparum or P. vivax parasites were not detected on any 
of the examined blood slides (Table 1). Available hospital 
records indicated 2/283 slide-conﬁ  rmed, RDT-conﬁ  rmed 
malaria cases in the study area in July and August 2008 
(T. Bousema, unpub. data). Travel history was not avail-
able for these persons. During August–September 2008, a 
total of 464 potential breeding sites were examined in Xu-
unshaley (n = 40), Badahabo (n = 42), and Ceel-Bardaale (n 
= 382). In Ceel-Bardaale, 158 Anopheles mosquito larvae 
were found at 81 of 382 examined sites. In the 2 other vil-
lages, no Anopheles larvae were observed.
Malaria Exposure Assessed by Immunologic Methods
In August–September 2008, serum samples were col-
lected from 1,128 persons in Xuunshaley (n = 271), Ba-
dahabo (n = 160), and Ceel-Bardaale (n = 697) (Table 2). 
In the 3 months before the survey, 19 persons reported 
having traveled to areas that are known to have higher 
malaria endemicity for a median of 4 (IQR 2–20) days. 
Persons who reported traveling to areas highly endemic 
for malaria were more likely to have a positive response 
to P. falciparum (odds ratio [OR] 2.62, 95% conﬁ  dence 
interval [CI] 0.98–7.01, p = 0.054) but not to P. vivax 
(OR 1.18, 95% CI 0.42–3.32, p = 0.75), after adjustment 
for age and village of residence. These 19 persons were 
excluded from further analyses.
All antigens tested showed a clear increase in sero-
prevalence with a person’s age (Figure 1). The data did not 
suggest a recent reduction in malaria transmission inten-
sity (14). The EIR for P. falciparum based on seroconver-
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sion rates for MSP-119 and AMA-1 (11) was <0.1 infec-
tious bites/person/year. When MSP-119 and AMA-1 data 
were combined, 17.9% (179/1,001) of the persons tested 
showed reactivity against P. falciparum (i.e., had antibod-
ies against P. falciparum MSP-119, AMA-1, or both) and 
19.3% (202/1,044) against P. vivax. There was a signiﬁ  cant 
positive association between reactivity against P. falcipar-
um and P. vivax (p<0.001). However, only 39.8% (66/166) 
of persons with antibodies against P. falciparum also re-
sponded against P. vivax antigens, and there was no appar-
ent correlation between antibody titers against antigens of 
the 2 malaria species (p>0.58).
Spatial Patterns in Seroreactivity
P. falciparum antibody prevalence was 9.4% (23/244) 
in Xuunshaley, 21.7% (30/138) in Badahabo (p = 0.001), 
and 20.4% (126/619) in Ceel-Bardaale (p<0.001) (Table 
2). P. vivax antibody prevalence was 16.1% (40/248) in 
Xuunshaley, 21.0% (31/148) in Badahabo (p = 0.11), and 
20.2% (131/648) in Ceel-Bardaale (p = 0.13) (Table 2).
Age-adjusted P. falciparum seroreactivity was signiﬁ  -
cantly increased in a cluster of 18 households (108 persons) 
in Ceel-Bardaale (p = 0.002) (Figure 2). In Xuunshaley, 
there was a small cluster of 6 households (27 persons) with 
a higher age-adjusted P. vivax seroreactivity (p = 0.005).
Factors Associated with Seroreactivity
Seroreactivity data were analyzed for villages sepa-
rately because villages were >7 km apart and were therefore 
likely to have their own transmission characteristics. In all 3 
villages, P. falciparum antibody prevalence increased with 
age (Table 3). For Ceel-Bardaale, an independent negative 
association was found between P. falciparum antibody re-
sponses and distance to the nearest seasonal river (OR 0.94, 
95% CI 0.88–0.99, p = 0.03) after adjustment for age and 
correlation between observations from the same household. 
Within the group of persons who had a positive antibody 
response against P. falciparum, the titer increased with age 
in Xuunshaley (β = 1.74, SE = 0.81, p = 0.031) and Ceel-
Bardaale (β = 11.48, SE = 3.49, p = 0.001).
Similar to P. falciparum, P. vivax antibody prevalence 
increased with age in all 3 villages (Table 3). For Ceel-
Bardaale, distance to the nearest seasonal river was nega-
tively associated with P. vivax immune response (OR 0.93, 
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Table 1. Characteristics of persons included in cross-sectional survey for Plasmodium falciparum and P. vivax infection, Somalia, 
2008*
Characteristic Dry season, Mar–Apr End of wet season, Aug–Sep 
No. persons  1,178 1,128
Age, y, median (IQR)  17 (6–36)  15 (6–37) 
Female 48.6 (573/1,178)  50.8 (573/1,128) 
Reported regular bed net use  1.9 (22/1,158)  2.2 (25/1,128) 
Reported fever in 14 d preceding survey  4.8 (57/1,179)  0.6 (7/1,128) 
Temperature >37.5°C at time of survey  0.8 (10/1,177)  1.1 (12/1,124) 
Positive rapid diagnostic test result  0 (0/1,173)  0 (0/1,106) 
Plasmodium falciparum parasite prevalence†  0 (0/1,173)  0 (0/1,106) 
P. vivax parasite prevalence†  0 (0/1,173)  0 (0/1,106) 
*IQR, interquartile range (25th75th percentile). Values are % (no. positive/no. tested) unless otherwise indicated.  
†Determined by screening 200 high-power microscopic fields. 
Table 2. Immune responses against Plasmodium falciparum and P. vivax in study participants, by village, Somalia, 2008* 
Village†
Characteristic Xuunshaley Badahabo Ceel-Bardaale  p value‡ 
No. persons  271 160 697
Median age, y (IQR)  20 (7–40)  17.5 (5–35)  13 (6–35)  0.04
P. falciparum immune response 
  Combined  9.4 (23/244)  21.7 (30/138)  20.4 (126/619)  <0.001
  MSP-1  5.1 (13/254)  13.4 (19/142)  15.0 (95/634)  <0.001
251.2 (155.0–285.3)  214.8 (169.8–275.5)  248.5 (190.5–397.2)  0.12
  AMA-1  4.8 (12/252)  9.2 (13/141)  8.9 (58/653)  0.02
169.1 (137.0–190.9)  189.3 (158.4–225.5)  233.7 (170.7–487.0)  0.12
P. vivax immune response
  Combined  16.1 (40/248)  21.0 (31/148)  20.2 (131/648)  0.33
  MSP-1  11.9 (30/252)  13.9 (21/151)  10.4 (58/648)  0.33
333.9 (271.4–463.9)  342.4 (280.1–374.8)  291.5 (248.7–393.3)  0.39
  AMA-1  5.2 (13/252)  7.4 (11/149)  12.8 (85/665)  0.001
151.5 (146.0–202.1)  183.5 (155.7–275.7)  227.1 (184.6–390.8)  0.10
*IQR, interquartile range (25th–75th percentile); MSP-1, merozoite surface protein 1; AMA-1, apical membrane antigen 1.  
†Values are % prevalence (no. positive/no. tested) or approximate median titer (IQR) only for seropositive persons unless otherwise indicated.  
‡Adjusted for age and correlations between observations from the same household, when applicable.  RESEARCH
95% CI 0.87–0.99, p = 0.02) after adjustment for age and 
correlation between observations from the same household. 
P. vivax antibody titer did not increase with age or any oth-
er factor in those persons who were seropositive. House-
hold factors, socioeconomic factors, distance to the nearest 
livestock enclosure, and use of mosquito netting were not 
independently associated with immune responses against 
P. falciparum or P. vivax.
Although seroprevalence and antibody titers were 
higher in older age groups, seroreactivity was also observed 
in young children. P. falciparum antibodies were detected 
in 22 children <5 years of age (median titer 216.5, IQR 
173.2–248.5); 10 had antibodies against P. vivax (median 
titer 220.1, IQR 190.4–262.4), and 2 of these children had 
antibodies against P. falciparum and P. vivax. Thirty chil-
dren <5 years of age who responded to malaria antigens 
were from all 3 villages (3 from Xuunshaley, 7 from Bada-
habo, and 20 from Ceel-Bardaale). Travel to areas in which 
malaria was highly endemic in the past 3 months was not 
reported for any of these children with antibodies against P. 
vivax, P. falciparum, or both. In children <5 years of age, a 
response against P. falciparum antigens was not related to 
a response against P. vivax antigens (p = 0.30).
Discussion
We showed that serologic markers can be used to de-
tect heterogeneity in malaria transmission in the Gebiley 
District of Somalia where malaria transmission occurs at 
levels too low to be detected by microscopy. None of the 
slides or rapid diagnostic tests showed parasite carriage in 
the population, and MSP-119 and AMA-1 seroprevalence 
data showed a clear increase in seroreactivity with age and 
evidence for variation in exposure to malaria between and 
within villages.
Malaria is perceived as a public health problem in the 
study area (22), and the 2 slide-conﬁ  rmed malaria cases con-
ﬁ  rm local clinical malaria episodes. Malaria transmission 
in the Gebiley District could not be conﬁ  rmed by micros-
copy or RDT in 2 large cross-sectional surveys in the gen-
eral population. However, our serologic ﬁ  ndings conﬁ  rmed 
the occurrence of malaria transmission in the area. Using a 
validated model to relate age-speciﬁ  c seroconversion rates 
to EIR (11), we estimated that P. falciparum transmission 
intensity in this area in Somalia was low (EIR <0.1 infec-
tious bites/person/year). Because of the longevity of anti-
body responses, this estimate should be interpreted as an 
average EIR experienced over several years. The low EIR 
appeared to be supported by examination of breeding sites 
at the end of the wet season, which conﬁ  rmed the presence 
of malaria vectors at a low density. We did not directly de-
termine the EIR by sampling adult mosquitoes because the 
low density of mosquitoes would have required intensive 
sampling over different seasons (6,23).
Serologic data showed a clear age-dependency in 
malaria-speciﬁ  c immune responses, which suggested ex-
posure-driven age acquisition of antibody response. Once 
acquired, antibody responses to MSP-119 and AMA-1 will 
persist for several years (L.C. Okell, unpub. data) (12), and 
the rate of acquisition in younger age groups is therefore 
critical for determining current malaria transmission in-
tensity. The maximum seroprevalence for individual ma-
laria antigens did not exceed 25% in the oldest age groups, 
which is comparable to areas of low malaria endemicity in 
northeastern Tanzania (12).
Because of the longevity of antibody responses, sero-
reactivity may not necessarily be the result of recent ex-
posure or exposure in the study area (11,24–26). Consid-
erable changes in transmission intensity in the study area 
would have been detected by the model (14). However, 
especially in adults, exposure to parasites earlier in life and 
a history of traveling to malaria-endemic areas can obscure 
immune responses resulting from recent local transmission 
(25). Our data indicate that although antibodies may have 
been acquired outside the study area, ongoing local ma-
laria transmission at a low intensity is likely. Elimination 
of false-positive results to reliably detect low-level local 
malaria transmission is necessary.
Cross-reactivity between immune responses to malaria 
and other parasites have been reported (27,28) but are ex-
pected to be more pronounced when whole parasite extract 
is used instead of recombinant proteins representing single 
antigens. The chance of cross-reactive antibody responses 
may be minimized by using sera at a minimum dilution of 
1:80 (27). Our serum samples were tested at considerably 
higher dilutions and we observed no relation in antibody 
titers between the homologous antigens of P. falciparum 
and P. vivax. Moreover, our method for calculating sero-
positivity derives its seronegative population from within 
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Table 3. Factors associated with Plasmodium falciparum or P. vivax seroprevalence in 3 villages, Somalia, 2008* 
P. falciparum P. vivax
Village Factor OR (95% CI)  p value  OR (95% CI)  p value 
Xuunshaley  Age 1.02 (1.00–1.04)  0.029 1.04 (1.02–1.06)  <0.001
Badahabo Age 1.03 (1.01–1.05)  0.002 1.03 (1.01–1.05)  0.006
Ceel-Bardaale  Age 1.03 (1.02–1.04)  <0.001 1.03 (1.02–1.04)  <0.001
Distance to river†  0.94 (0.88–0.99)  0.028 0.93 (0.88–0.99)  0.016
*OR, odds ratio; CI, confidence interval. Estimates are adjusted for correlation between observations from the same household. 
†Nearest seasonal river. Serologic Markers for Detecting Malaria
the study sample, thereby minimizing bias caused by local 
cross-reactive antigens. Although this method does not rule 
out cross-reactive antigens, it makes it unlikely. Antibody 
responses in young children who are unlikely to have ac-
quired infections outside the study area, and for whom no 
recent travel history was reported, also suggest recent ma-
laria transmission. In our study area, several children <5 
years of age had antibody titers >200 to P. falciparum (n = 
17) or P. vivax (n = 6). The presence of strong antibody re-
sponses (indirect ﬂ  uorescent antibody titer >20) in children 
<15 years of age was used as evidence for active transmis-
sion of malaria in area of low endemicity in Middle Amer-
ica (Costa Rica) (25,26).
The indication for local malaria transmission we pro-
vide in this study is relevant for local health workers who 
should be prepared for fever investigations with standard 
parasitologic techniques (microscopy and RDT). Malaria 
should be considered as a plausible cause of febrile illness, 
particularly in an epidemic form. Low-intensity malaria 
transmission and the presence of malaria vectors make the 
area susceptible to malaria epidemics, which can have a 
high mortality rate in resource-poor areas (29), especially 
if outbreak detection systems (30) are not feasible because 
of a poor health infrastructure.
We observed heterogeneity in seroreactivity within the 
study area. Although the 3 villages had low transmission 
intensity and showed no difference in microscopic parasite 
carriage, serologic markers showed variation in malaria 
exposure. Antibody prevalence against P. falciparum and, 
less markedly, P. vivax were lowest in Xuunshaley, which 
was furthest from seasonal rivers. Combined P. falciparum 
MSP-119 and AMA-1 antibody prevalence was 2× higher in 
Badahabo and Ceel-Bardaale than in Xuunshaley. SaTScan 
analysis indicated heterogeneity in malaria exposure at a 
microepidemiologic level. We observed 1 statistically sig-
niﬁ  cant cluster of persons with higher seroreactivity against 
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Figure 1. Seroprevalence data for antibodies against A) Plasmodium falciparum merozoite surface protein 119 (MSP-119), B) P. falciparum 
apical membrane antigen 1 (AMA-1), C) P. vivax MSP-119, and D) P. vivax AMA-1 by age in the study population, Somalia, 2008. Gray 
lines indicate 95% conﬁ  dence intervals. Seroconversion rates (95% conﬁ  dence intervals) were as follows: P. falciparum MSP-119 0.0082 
(0.0068–0.097); AMA-1 0.0053 (0.0042–0.0066); P. vivax MSP-119 0.0086 (0.0055–0.0133); AMA-1 0.0075 (0.0050–0.0112).RESEARCH
P. falciparum and 1 with higher seroreactivity against P. 
vivax. In Ceel-Bardaale, where households were scattered 
along a delta of seasonal rivers, antibody prevalences to P. 
falciparum and P. vivax were negatively associated with 
distance to the nearest river. In several areas of higher en-
demicity, distance to the nearest body of water has been 
related to malaria incidence (5,20,31,32) and immune re-
sponses (20,32). No other factors were signiﬁ  cantly related 
to malaria-speciﬁ  c immune responses.
Our data indicate that serologic markers can be used 
to determine variation in transmission intensity at levels 
of malaria transmission that are too low for sensitive as-
sessments by microscopy, RDT, or entomologic tools. 
The sensitivity of serologic analysis to detect small-scale 
differences in transmission intensity may prove extreme-
ly useful in evaluating malaria control programs in areas 
where conventional malariometric markers fail. It may 
also provide vital information on which areas are most 
likely to be receptive to transmission if malaria epidemics 
were to occur.
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